BSE Live
Dec 10, 16:01Prev. Close
190.10
Open Price
189.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:52Prev. Close
190.11
Open Price
189.61
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
191.21 (20587)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 52.73 | 56.01 | 16.65 | 11.95 | 91.63 | |
| Net CashFlow From Operating Activities | 118.01 | 19.81 | 15.63 | -13.62 | 64.76 | |
| Net Cash Used In Investing Activities | -24.10 | -20.20 | -7.55 | -7.69 | -177.34 | |
| Net Cash Used From Financing Activities | -92.29 | 0.96 | -9.98 | 20.74 | -51.83 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 1.63 | 0.56 | -1.90 | -0.57 | -164.41 | |
| Cash And Cash Equivalents Begin of Year | 1.12 | 0.55 | 2.45 | 3.13 | 167.54 | |
| Cash And Cash Equivalents End Of Year | 2.75 | 1.12 | 0.55 | 2.56 | 3.13 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y